4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-013273
CEO sold 3,928 shares at $23.80 ($93,486)
- CEO acquired 10,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2022-02-23 | Option exercise | +10,945 | 69,661 | D | ||
| DAVIS STEPHEN CEO | 2022-02-23 | Sale | −3,928 | $23.80 | $93,486 | 65,733 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2022-02-23 | Option exercise · Restricted Stock Units | +10,945 | 32,837 | D | ||
| Open-market sales · 3,928 sh · avg $23.80 · $93,486 | |||||||
Loading xslF345X03/doc4.xml…